Yidu Tech

Yidu Tech CapEx/OCF

The CapEx to Operating Cash Flow Ratio of Yidu Tech (2158.HK) as of Nov 4, 2026 is -134.71 %. In the previous year, CapEx to Operating Cash Flow Ratio was -40.98 % — a change of 228.72% (lower).

CapEx/OCF

-134.71 %

YoY

228.72%

Last updated:

CapEx to Operating Cash Flow Ratio of Yidu Tech is 2026 -134.71 % . CapEx to Operating Cash Flow Ratio of Yidu Tech was 2025 -40.98 % . It decreases by 228.72% lower compared to the previous year.

The Yidu Tech CapEx/OCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CapEx/OCF
Date
CapEx/OCF
Jan 1, 2019
-12.74 CNY
Jan 1, 2020
-8.75 CNY
Jan 1, 2021
-5.74 CNY
Jan 1, 2022
-9.35 CNY
Jan 1, 2023
-4.93 CNY
Jan 1, 2024
-12.50 CNY
Jan 1, 2025
-40.98 CNY
Jan 1, 2026
-134.71 CNY
The Yidu Tech CapEx/OCF history
YEARCapEx/OCFYoY
-134.71 %+228.72%
-40.98 %+227.72%
-12.50 %+153.83%
-4.93 %-47.31%
-9.35 %+62.80%
-5.74 %-34.35%
-8.75 %-31.35%
-12.74 %+4.89%
-12.15 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Yidu Tech Stock analysis

What does Yidu Tech do? Yidu Tech, Inc. generates revenue through three core business segments. The Big Data Platform and Solutions segment offers big data platform services and related solutions to customers. The Life Science Solutions segment provides analysis-driven clinical development, real-world evidence (RWE)-based research, and digital commercialization solutions to pharmaceutical, biotech, and medical device companies. The Health Management Platform and Solutions segment delivers research-driven personal health management platforms and insurance technology and disease management solutions to insurance companies and agencies. The company's primary data intelligence infrastructure, YiduCore, supports these offerings. The firm's customers include pharmaceutical, biotech, and medical device companies in the Life Science Solutions segment, while insurance companies and agencies are key clients for the Health Management Platform and Solutions segment. Big data platform services are sold to a broader customer base under the Big Data Platform and Solutions segment. YiduCore serves as the foundational infrastructure enabling the delivery of all data-driven solutions across the company's segments. Revenue streams are derived from data platform services, clinical development solutions, RWE-based research, digital commercialization, health management platforms, and insurance technology solutions. The company's business model leverages its YiduCore infrastructure to provide tailored data intelligence services to specialized industry segments, including life sciences and health management sectors. Yidu Tech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Yidu Tech stock

CapEx to Operating Cash Flow Ratio of Yidu Tech is -134.71 % in 2026.

CapEx to Operating Cash Flow Ratio of Yidu Tech changed from -40.98 % to -134.71 %, representing a 228.72% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of CapEx to Operating Cash Flow Ratio Yidu Tech since 2006 – with annual values, charts, and detailed analysis.

The CapEx/OCF ratio shows what percentage of operating cash flow is reinvested in capital assets. Lower ratios indicate more free cash available for shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare CapEx to Operating Cash Flow Ratio's Yidu Tech with sector peers and the industry average to assess whether it is attractive.

To evaluate CapEx to Operating Cash Flow Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for CapEx to Operating Cash Flow Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Yidu Tech

All Key Metrics — Yidu Tech